Skip to main content

Table 2 Associations between FBP1 and -3 and clinical parameters in RCC (low, high expression: for definition see text).

From: The FUSE binding proteins FBP1 and FBP3 are potential c-myc regulators in renal, but not in prostate and bladder cancer

   FPB1 FBP3
   n low
n (%)
high
n (%)
p-value n low
n (%)
high
n (%)
p-value
Histology clear cell 83 58
(69.9)
25
(30.1)
0.003# 83 51
(61.4)
32
(38.6)
0.052#
  papillary 16 5
(31.3)
11
(68.8)
  17 5
(29.4)
12
(70.6)
 
  chromo-phobe 5 5
(100.0)
0
(0)
  5 3
(60.0)
2
(40.0)
 
pT
Stage*
pT1/2 40 30
(75.0)
10
(25.0)
n.s. 40 19
(47.5)
21
(52.5)
0.014
  pT3/4 43 28
(65.1)
15
(34.9)
  43 32
(74.4)
11
(25.6)
 
Grade* 1/2 66 48
(72.7)
18
(27.3)
n.s. 66 43
(65.2)
23
(34.8)
n.s.
  3/4 17 10
(58.8)
7
(41.2)
  17 8
(47.1)
9
(52.9)
 
FBP1 low 58     58 41
(70.7)
17
(29.3)
0.013
  high 25     25 10
(40.0)
15
(60.0)
 
FBP3 low 51 41
(80.4)
10
(19.6)
0.013 51    
  high 32 17
(53.1)
15
(46.9)
  32    
  1. n.s.: not significant
  2. * only clear cell RCC
  3. # Chi square test